Setting the record straight: The origin of the pharmacophore concept

Journal of Chemical Information and Modeling

Volumn 54, Issue 5, 2014, Pages 1269-1283

  Güner, Osman F ^a   Bowen, J Phillip ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULES;

BIOLOGICAL EFFECTS; CHEMICAL GROUP; CURRENT DEFINITION; PHARMACOPHORES; SPATIAL PATTERNS;

PHARMACODYNAMICS;

CHEMICAL STRUCTURE; CONFORMATION; DRUG DEVELOPMENT; NOMENCLATURE;

DRUG DISCOVERY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; TERMINOLOGY AS TOPIC;

EID: 84901640599     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci5000533     Document Type: Review

References (67)

1. Wermuth, C.-G.; Ganellin, C. R.; Lindberg, P.; Mitscher, L. A. Glossary of Terms used in medicinal chemistry (IUPAC recommendations 1998) Pure Appl. Chem. 1998, 70, 1129-1143
2. Ehrlich, P. Über den jetzigen Stand der Chemotherapie Ber. Dtsch. Chem. Ges. 1909, 42, 17-47
3. Ariëns, E. J. Molecular pharmacology, a basis for drug design Prog. Drug Res. 1966, 10, 429-529
4. Gund, P. Three-Dimensional Pharmacophoric Pattern Searching. In Progress in Molecular and Subcellular Biology; Hahn, F. E., Ed.; Springer-Verlag: Berlin, 1977; Vol. 11, pp 117-143.
5. Gund, P. Pharmacophoric Pattern Searching and Receptor Mapping. In Annual Reports in Medicinal Chemistry; Academic Press: New York, 1979; Vol. 14, pp 299-308.
6. Gund, P. Evolution of the Pharmacophore Concept in Pharmaceutical Research. In Pharmacophore Perception Development and Use in Drug Design; Güner, O. F., Ed.; International University Line: La Jolla, CA, 2000; pp 3-11.
7. Güner, O. F. History and evolution of the pharmacophore concept in computer-aided drug design Curr. Top Med. Chem. 2002, 2, 1321-1332
8. Khedkar, S. A.; Malde, A. P.; Coutinho, E. J.; Srivastava, S. Pharmacophore modeling in drug discovery and development: An overview Med. Chem. 2007, 3, 187-197
9. Yang, S.-Y. Pharmacophore modeling and applications in drug discovery: Challenges and recent advances Drug Discovery Today 2010, 15, 444-450
10. Van Drie, J. H. Monty Kier and the origin of the pharmacophore concept Internet Electron. J. Mol. Des. 2007, 6, 271-279
11. Langer, T. Pharmacophores in drug research Mol. Inf. 2010, 29, 470-475
12. Caporuscio, F.; Tafi, A. Pharmacophore modelling: A forty year old approach and its modern synergies Curr. Med. Chem. 2011, 18, 2543-2553
13. Cross, S.; Cruciani, G. Grid-derived structure-based 3D pharmacophores and their performance compared to docking Drug Discovery Today: Technol. 2010, 7, e213-e219
14. Langer, T. Pharmacophores for medicinal chemists: A personal view Future Med. Chem. 2011, 3, 901-904
15. Cross, S.; Baroni, M.; Goracci, L.; Cruciani, G. GRID-based three-dimensional pharmacophores I: FLAPpharm, a novel approach for pharmacophore elucidation J. Chem. Inf. Model. 2012, 52, 2587-2598
16. Braga, R. C.; Andrade, C. H. Assessing the performance of 3D pharmacophore models in virtual screening: How good are they? Curr. Top. Med. Chem. 2013, 13, 1127-1138
17. Shin, W.-J.; Seong, B. L. Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery Expert Opin. Drug Discovery 2013, 8, 411-426
18. May, P. The Chemistry of Synthetic Drugs; Longmans, Green, and Co.: London, 1911.
19. Pharmacophore Perception, Development, and Use in Drug Design; Güner, O. F., Ed.; International University Line: La Jolla, CA, 2000.
20. Achilladelis, B. Innovation in the Pharmaceutical Industry. In Pharmaceutical Innovation: Revolutionizing Human Health; Landau, R.; Achilladelis, B.; Scriabine, A., Eds.; The Chemical Heritage Foundation Series in Innovation and Entrepreneurship; Chemical Heritage Press: Philadelphia, 1999; pp 1-147.
21. Kier, L. B. Molecular orbital calculation of preferred conformations of acetylcholine, muscarine, and muscarone Mol. Pharmacol. 1967, 3, 487-494
22. Kier, L. B. Molecular Orbital Theory in Drug Research; Medicinal Chemistry-A Series of Monographs; Academic Press: New York, 1971; Vol. 10.
23. Kier, L. B. Receptor Mapping Using Molecular Orbital Theory. In Fundamental Concepts in Drug-Receptor Interactions; Academic Press: New York, 1970; pp 15-46.
24. Beckett, A. H.; Harper, N. J.; Clitherow, J. W. The impact of stereoisomerism in muscarinic activity J. Pharm. Pharmacol. 1963, 15, 362-371
25. Barlow, R. B. Introduction to Chemical Pharmacology; 2 nd ed.; Methuen: London, 1964.
26. Bebbington, A.; Brimblecombe, R. W. Muscarinic receptor in peripheral and central nervous systems Adv. Drug Res. 1965, 2, 143-172
27. Nettles, J. H.; Downing, K. H. The Tubulin Binding Mode of Microtubule Stabilizing Agents Studied by Electron Crystallography. In Tubulin-Binding Agents, Synthetic, Structural, and Mechanistic Insights; Carlomango, T., Ed.; Topics in Current Chemistry; Springer: Berlin, 2009; Vol. 286, pp 209-257.
28. Ehrlich, P. Ansprache bei Einweihung des Georg-Speyer-Hauses. In The Collected Papers of Paul Ehrlich-Vol. 3-Chemotherapy; Himmelweit, F.; Marquardt, M.; Dale, H., Eds.; Pergamon Press: London, 1960; Vol. 3, pp 42-52.
29. Morgagni, J. B. de Sedipus et Causis Morborum per Anatomen Indagatis; Apud M. C. Compere: Juniorem, Bibliopolam, Medica Schole Vico, 1771.
30. Garrison, F. H. Ehrlich's specific therapeutics in relation to scientific method Popular Sci. Monthly 1911, 78, 209-222
31. Parascandola, J. Origins of the receptor theory of drug action Bull. Hist. Med. 1974, 48, 199-220
32. Parascandola, J. The theoretical basis of Paul Ehrlich's chemotherapy J. Hist. Med. 1981, 36, 19-43
33. Ehrlich, P. The Relations Existing between Chemical Constitution, Distribution, and Pharmacological Action. In The Collected Papers of Paul Ehrlich-Vol. I-Histology, Biochemistry, and Pathology; Himmelweit, F.; Marquardt, M.; Dale, H., Eds.; Pergamon Press: London, 1956; Vol. 1, p 613.
34. Ehrlich, P. On Immunity with Special Reference to Cell Life. In The Collected Papers of Paul Ehrlich-Vol. II-Immunology and Cancer Research; Himmelweit, F.; Marquardt, M.; Dale, H., Eds.; Pergamon Press: London, 1957; Vol. 2, p 185.
35. Ehrlich, P. Chemotherapy. In The Collected Papers of Paul Ehrlich-Vol. III-Chemotherapy; Himmelweit, F.; Marquardt, M.; Dale, H., Eds.; Pergamon Press: London, 1960; Vol. 3, pp 507-511.
36. Achilladelis, B. Destination unforseen; the birth of research intensive pharmaceutical industry Chem. Heritage 1998, 15 (6-7) 37-39
37. Daemmrich, A.; Bowden, M. The top pharmaceuticals that change the world. Chem. Eng. News 2005, 83.
38. Lykknes, A.; Kvittingen, L. Arsenic: Not so evil after all? J. Chem. Educ. 2003, 80, 497
39. Levinson, A. S. The structure of Salvarsan and the arsenic-arsenic double bond J. Chem. Educ. 1977, 54, 98
40. Lloyd, N. C.; Morgan, H. W.; Nicholson, B. K.; Ronimus, R. S. The composition of Ehrlich's Salvarsan: Resolution of a century-old debate Angew. Chem., Int. Ed 2005, 44, 941-944
41. Sevrioukova, I. F.; Poulos, T. L. Structural and mechanistic insights into the interaction of cytochrome P4503A4 with Bromoergocryptine, a type I ligand J. Biol. Chem. 2012, 287, 3510-3517
42. Hart, M. C.; Payne, W. B. On 3-amino-4-hydroxyarsenophenyl- 4′glycine and its N -methylenesulphinate and N -methylenesulphomate derivatives J. Am. Pharm. Assoc 1923, 12, 759-768
43. Korolkovas, A. Essentials of Molecular Pharmacology; Interscience: New York, 1970.
44. Gund, P.; Wipke, W. T.; Langridge, R. Computer Searching for Molecular Structure File for Pharmacophoric Patterns. In Computers in Chemical Research and Education. Proceedings of the International Conference, Lubljana, Zagreb, July12-17, 1973; Hadzi, D.; Zupan, J., Eds.; Elsevier Scientific: Amsterdam, 1973; Vol. 3, pp 5-33.
45. Marshall, C. R. On the physiological action of the alkaloids of jaborandi leaves J. Physiol. 1904, 31, 120-156
46. Paschall, B. S. Substance for Treatment of Tuberculosis, Leprosy, and Other Diseases and Process of Mixing Said Substance. U.S. Patent 1,250,345, December 18, 1917.
47. Gilman, H.; Pickens, R. M. The correlation of some aromatic types with physiological action. local anesthetics containing the furan, thiophene, and pyrrole nuclei J. Am. Chem. Soc. 1925, 47, 245-254
48. Wermuth, C.-G. Pharmacophores: Historical Perspective and Viewpoint from a Medicinal Chemist. In Pharmacophores and Pharmacophore Searches; Langer, T.; Hoffmann, R., Eds.; Methods and Principles in Medicinal Chemistry; WileY-VCH: Weinheim, Germany, 2006; Vol. 32, pp 1-13.
49. Whitehouse, M. W. Biochemical properties of anti-inflammatory drugs-III Biochem. Pharmacol. 1964, 13, 319-336
50. Schueler, F. W. Chemobiodynamics and Drug Design; McGraw-Hill: New York, 1960.
51. Ehrlich, P. Über die Constitution des Diphtheriegiftes Deut. Med. Wochschr. 1898, 24, 597-600
52. Ehrlich, P. Beiträge zur experimentellen Pathologie und Chemotherapie; Akademische Verlagsgesellschaft m. b. H.: Leipzig, 1909; Vol. 3.
53. Beckett, A. H.; Casy, A. F. Synthetic analgesics: Stereochemical considerations J. Pharm. Pharmacol. 1954, 6, 986-1001
54. Beckett, A. H.; Casy, A. F. Analgesics and their antagonists: Biochemical aspects and structure-activity relationships Prog. Med. Chem. 1965, 4, 171-218
55. Beckett, A. H. Stereochemical Factors in Biological Activity. In Forschritte der Arzneimittelforschung; Jucker, E., Ed.; Birkhauser Verlag: Basel, 1959; Vol. I, pp 455-530.
56. Marshall, G. R.; Barry, C. D.; Bosshard, H. E.; Dammkoehler, R. A.; Dunn, D. A. The Conformational Parameter in Drug Design: The Active Analog Approach. In Computer-Assisted Drug Design; Olson, E. C.; Christoffersen, R. E., Eds.; ACS Symposium Series 112; American Chemical Society: Washington DC, 1979; pp 205-226.
57. Pearlman, R. S. Rapid generation of high quality approximate 3D molecular structures Chem. Des. Autom. News 1987, 2, 1-7
58. Hiller, C.; Gasteiger, J. Ein automatisierter molekülbaukasten. In Software-Entwicklung in der Chemie; Gasteiger, J., Ed.; Springer: Berlin, 1987; Vol. 1, pp 53-66.
59. Wipke, W. T.; Hahn, M. A. AIMB: Analogy and intelligence in model building. System description and performance characteristics Tetrahedron Comput. Methodol. 1988, 1, 141
60. Dolata, P. D.; Leach, A. R.; Prout, K. Wizard: AI in conformational analysis J. Comput.-Aided Mol. Des. 1987, 1, 73-85
61. Christie, B. D.; Henry, D. R.; Güner, O. F.; Moock, T. E. MACCS-3D: A tool for three-dimensional drug design. In Online Information '90, 14th International Online Information Meeting Proceedings; Rait, D. I., Ed.; Learned Information: Oxford, 1990; pp 137-161.
62. Güner, O. F.; Hughes, D. W.; Dumont, L. M. An integrated approach to three-dimensional information management with MACCS-3D J. Chem. Inf. Comput. Sci. 1991, 31, 408-414
63. Van Drie, J. H.; Weininger, D.; Martin, Y. C. ALADDIN: An integrated tool for computer assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures J. Comput.-Aided Mol. Des. 1989, 3, 225-251
64. Lewis, G. L. The conservation of photons Nature 1926, 118, 874-875
65. Compton, A. H. Nobel Lecture: X-rays as a Branch of Optics, 1927. Nobelprize.org. Nobel Media AB 2013. http://www.nobelprize.org/nobel-prizes/ physics/laureates/1927/compton-lecture.html (accessed April 8, 2014).
66. Okun, L. B. Photon: History, mass, charge Acta Phys. Pol., B 2006, 37, 565-573
67. Walker, C. T. Who named the -ON's? Am. J. Phys. 1970, 38, 1380